← Leaderboards
William V Tamborlane
Yale University
$15,237,030
Attributed
$17,821,563
Total exposure
32
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,821,563 · 32
By mechanism
T32$6,077,228 · 2
K12$5,985,304 · 2
P30$2,547,391 · 4
U01$1,317,950 · 1
M01$1,259,403 · 22
U10$634,287 · 1
Top collaborators
- John J Wysolmerski14 shared
- Robert Stanley Sherwin9 shared
Most similar at Yale University
Same institution · by research overlap
- Gerald I Shulman$43,949,903
- David Fiellin$24,843,505
- Douglas Lyle Rothman$20,115,119
- Marjorie Funk$6,169,567
- Janice Jin Hwang$5,677,315
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectClinical TrialsDiabetes MellitusInsulinInsulin Dependent Diabetes MellitusHuman Therapy EvaluationDiabetes Mellitus TherapyHypoglycemiaMetabolic DiseasesAdolescence (12-20)Child (0-11)PediatricsPositron-Emission TomographyCollaborationsMedical SchoolsResearch FacilityResearch PersonnelResourcesFundingTrainingAge DifferenceDrug Screening /EvaluationArea
Grant awards (122)
Diabetes Translational Research Core$179,974
P30 · FY2025 · DK · contact PI
Diabetes Translational Research Core$198,861
P30 · FY2024 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$485,445
T32 · FY2023 · DK
Diabetes Translational Research Core$213,030
P30 · FY2023 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$488,229
T32 · FY2022 · DK
Diabetes Translational Research Core$213,668
P30 · FY2022 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$411,915
T32 · FY2021 · DK
Diabetes Translational Research Core$213,670
P30 · FY2021 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$484,720
T32 · FY2020 · DK
Career Development Programs in Diabetes Research for Pediatrics Endocrinologists$400,549
K12 · FY2020 · DK · contact PI
Diabetes Translational Research Core$213,668
P30 · FY2020 · DK · contact PI
Career Development Programs in Diabetes Research for Pediatrics Endocrinologists$400,389
K12 · FY2019 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$395,526
T32 · FY2019 · DK
Diabetes Translational Research Core$213,670
P30 · FY2019 · DK · contact PI
Career Development Programs in Diabetes Research for Pediatrics Endocrinologists$581,881
K12 · FY2018 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$460,754
T32 · FY2018 · DK
Diabetes Translational Research Core$213,670
P30 · FY2018 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$30,806
T32 · FY2018 · DK
Diabetes Mellitus and Disorders of Metabolism$426,798
T32 · FY2017 · DK
Career Development Programs in Diabetes Research for Pediatrics Endocrinologists$400,549
K12 · FY2017 · DK · contact PI
Core E: DIABETES TRANSLATIONAL RESEARCH CORE$170,674
P30 · FY2017 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$31,368
T32 · FY2017 · DK
Diabetes Mellitus and Disorders of Metabolism$2,740
T32 · FY2017 · DK
Career Development Programs in Diabetes Research for Pediatrics Endocrinologists$400,549
K12 · FY2016 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$400,179
T32 · FY2016 · DK
Core E: DIABETES TRANSLATIONAL RESEARCH CORE$170,674
P30 · FY2016 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$390,985
T32 · FY2015 · DK
Career Development Programs in Diabetes Research for Pediatric Endocrinologists$363,568
K12 · FY2015 · DK · contact PI
Core E: DIABETES TRANSLATIONAL RESEARCH CORE$170,674
P30 · FY2015 · DK · contact PI
Career Development Programs in Diabetes Research for Pediatric Endocrinologists$380,228
K12 · FY2014 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$375,168
T32 · FY2014 · DK
Core E: DIABETES TRANSLATIONAL RESEARCH CORE$170,674
P30 · FY2014 · DK · contact PI
Diabetes Mellitus and Disorders of Metabolism$58,625
T32 · FY2014 · DK
Career Development Programs in Diabetes Research for Pediatric Endocrinologists$567,336
K12 · FY2013 · DK · contact PI
Core E: DIABETES TRANSLATIONAL RESEARCH CORE$204,484
P30 · FY2013 · DK · contact PI
Career Development Programs in Diabetes Research for Pediatric Endocrinologists$388,414
K12 · FY2012 · DK · contact PI
Training in Pediatric Endocrinology and Diabetes Research$200,488
T32 · FY2012 · DK · contact PI
Career Development Programs in Diabetes Research for Pediatric Endocrinologists$388,414
K12 · FY2011 · DK · contact PI
Training in Pediatric Endocrinology and Diabetes Research$151,016
T32 · FY2011 · DK · contact PI
Training in Pediatric Endocrinology and Diabetes Research$209,884
T32 · FY2010 · DK · contact PI
Training in Pediatric Endocrinology and Diabetes Research$200,311
T32 · FY2009 · DK · contact PI
Training in Pediatric Endocrinology and Diabetes Research$157,429
T32 · FY2008 · DK · contact PI
Training in Pediatric Endocrinology/Diabetes Research$166,269
T32 · FY2006 · DK · contact PI
OUTCOMES OF TYPE 1 DIABETES IN CHILDREN$468,420
M01 · FY2005 · RR
Pediatric Endocrine/Diabetes Physician Scientists$428,852
K12 · FY2005 · DK
Training in Pediatric Endocrinology/Diabetes Research$56,263
T32 · FY2005 · DK
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS$25,141
M01 · FY2005 · RR
IMPLANTABLE INSULIN PUMP$2,206
M01 · FY2005 · RR
Pediatric Endocrine/Diabetes Physician Scientists$428,852
K12 · FY2004 · DK
Training in Pediatric Endocrinology/Diabetes Research$164,169
T32 · FY2004 · DK
Epidemiology of Diabetes Interventions and Complications$93,083
M01 · FY2004 · RR
Pediatric Endocrine/Diabetes Physician Scientists$428,852
K12 · FY2003 · DK
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$283,402
U01 · FY2003 · HD
Training in Pediatric Endocrinology/Diabetes Research$165,617
T32 · FY2003 · DK
Pediatric Endocrine/Diabetes Physician Scientists$426,871
K12 · FY2002 · DK
Yale Center in The Children's Glucose Sensor Network$383,157
U10 · FY2002 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$293,588
U01 · FY2002 · HD
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$176,494
U01 · FY2002 · HD
Training in Pediatric Endocrinology/Diabetes Research$162,524
T32 · FY2002 · DK
METFORMIN HYDROCHLORIDE FOR TREATMENT OF ADOLESCENTS WITH TYPE 2 DIABETES$0
M01 · FY2002 · RR
MECHANISMS OF GLUCOSE INTOLERANCE IN CHILDREN WITH IDDM$0
M01 · FY2002 · RR
EFFECTS OF HOSPITALIZATION ON DIABETES MANAGEMENT$0
M01 · FY2002 · RR
EFFECTS OF PUBERTY ON GLUCOSE KINETICS$0
M01 · FY2002 · RR
HORMONAL, SYMPTOMATIC AND NEUROPHYSIOLOGIC RESPONSE TO SUGAR INTAKE IN CHILDREN$0
M01 · FY2002 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$0
M01 · FY2002 · RR
NOCTURNAL HYPOGLYCEMIA EFFECT ON SLEEP PATTERNS OF DIABETIC CHILDREN$0
M01 · FY2002 · RR
COMPASSIONATE USE OF INHALED INSULIN IN ONE ADOLESCENT$0
M01 · FY2002 · RR
IMPLANTABLE PUMP SYSTEM AND INSULIN IN PATIENT UNABLE TO ACHIEVE GLYCEMIC CONTROL$0
M01 · FY2002 · RR
EFFICACY AND SAFETY OF INHALED INSULIN COMPARED TO SUBCUTANEOUS HUMAN INSULIN$0
M01 · FY2002 · RR
EFFICACY OF METFORMIN HYDROCHLORIDE PLUS INSULIN COMPARED TO INSULIN MONOTHERAPY$0
M01 · FY2002 · RR
TOLERABILITY AND PHARMACOKINETICS OF INHALED INSULIN IN CHILDREN 6 TO 11 YEARS$0
M01 · FY2002 · RR
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$286,445
U01 · FY2001 · HD
Yale Center in The Children's Glucose Sensor Network$251,130
U10 · FY2001 · HD
EFFICACY OF METFORMIN HYDROCHLORIDE PLUS INSULIN COMPARED TO INSULIN MONOTHERAPY$0
M01 · FY2001 · RR
METFORMIN HYDROCHLORIDE FOR TREATMENT OF ADOLESCENTS WITH TYPE 2 DIABETES$0
M01 · FY2001 · RR
HORMONAL, SYMPTOMATIC AND NEUROPHYSIOLOGIC RESPONSE TO SUGAR INTAKE IN CHILDREN$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$0
M01 · FY2001 · RR
RESPONSES TO HYPOGLYCEMIA IN INSULIN DEPENDENT DIABETES MELLITUS$0
M01 · FY2001 · RR
NOCTURNAL HYPOGLYCEMIA EFFECT ON SLEEP PATTERNS OF DIABETIC CHILDREN$0
M01 · FY2001 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS (EDIC)$0
M01 · FY2001 · RR
COMPASSIONATE USE OF INHALED INSULIN IN ONE ADOLESCENT$0
M01 · FY2001 · RR
MECHANISM OF GLUCOSE INTOLERANCE IN PREADOLESCENT/ADOLESCENT CHILDREN WITH IDDM$0
M01 · FY2001 · RR
IMPLANTABLE PUMP SYSTEM AND INSULIN IN PATIENT UNABLE TO ACHIEVE GLYCEMIC CONTROL$0
M01 · FY2001 · RR
EFFECTS OF HOSPITALIZATION ON DIABETES MANAGEMENT$0
M01 · FY2001 · RR
EFFECTS OF PUBERTY ON GLUCOSE KINETICS$0
M01 · FY2001 · RR
EFFICACY AND SAFETY OF INHALED INSULIN COMPARED TO SUBCUTANEOUS HUMAN INSULIN$0
M01 · FY2001 · RR
EFFECTS OF PUBERTY ON GLUCOSE KINETICS$0
M01 · FY2001 · RR
TOLERABILITY AND PHARMACOKINETICS OF INHALED INSULIN IN CHILDREN 6 TO 11 YEARS$0
M01 · FY2001 · RR
MECHANISMS OF GLUCOSE INTOLERANCE IN CHILDREN WITH IDDM$0
M01 · FY2001 · RR
RESPONSE TO HYPOGLYCEMIA IN INSULIN DEPENDENT DIABETES MELLITUS$317,355
M01 · FY2000 · RR
PEDIATRIC PHARMACOLOGY RESEARCH UNIT$278,021
U01 · FY2000 · HD
EPIDEMIOLOGY OF DIABETES INTERVENTION AND COMPLICATIONS (EDIC)$34,535
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL TYPE I DIABETES (DPT 1)$34,535
M01 · FY2000 · RR
RESPONSES TO HYPOGLYCEMIA IN INSULIN DEPENDENT DIABETES MELLITUS$34,535
M01 · FY2000 · RR
EFFECTS OF PUBERTY ON GLUCOSE KINETICS$34,535
M01 · FY2000 · RR
LONG TERM EFFECTS OF HOSPITALIZATION ON DIABETES MANAGEMENT$34,535
M01 · FY2000 · RR
NOCTURNAL HYPOGLYCEMIA EFFECT ON SLEEP PATTERNS OF DIABETIC CHILDREN$25,789
M01 · FY2000 · RR
MECHANISMS OF GLUCOSE INTOLERANCE IN CHILDREN WITH IDDM$25,789
M01 · FY2000 · RR
EFFECTS OF HOSPITALIZATION ON DIABETES MANAGEMENT$25,789
M01 · FY2000 · RR
EFFECTS OF PUBERTY ON GLUCOSE KINETICS$25,789
M01 · FY2000 · RR
HORMONAL, SYMPTOMATIC AND NEUROPHYSIOLOGIC RESPONSE TO SUGAR INTAKE IN CHILDREN$25,789
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$25,789
M01 · FY2000 · RR
RESPONSE TO HYPOGLYCEMIA IN INSULIN DEPENDENT DIABETES MELLITUS$25,789
M01 · FY2000 · RR
MECHANISM OF GLUCOSE INTOLERANCE IN PREADOLESCENT/ADOLESCENT CHILDREN WITH IDDM$0
M01 · FY2000 · RR
TOLERABILITY AND PHARMACOKINETICS OF INHALED INSULIN IN CHILDREN 6 TO 11 YEARS$0
M01 · FY2000 · RR
TOLERABILITY AND PHARMACOKINETICS OF INHALED INSULIN IN CHILDREN 6 TO 11 YEARS$0
M01 · FY2000 · RR
EFFICACY OF METFORMIN HYDROCHLORIDE PLUS INSULIN COMPARED TO INSULIN MONOTHERAPY$0
M01 · FY2000 · RR
EFFICACY OF METFORMIN HYDROCHLORIDE PLUS INSULIN COMPARED TO INSULIN MONOTHERAPY$0
M01 · FY2000 · RR
METFORMIN HYDROCHLORIDE FOR TREATMENT OF ADOLESCENTS WITH TYPE 2 DIABETES$0
M01 · FY2000 · RR
METFORMIN HYDROCHLORIDE FOR TREATMENT OF ADOLESCENTS WITH TYPE 2 DIABETES$0
M01 · FY2000 · RR
EFFICACY AND SAFETY OF INHALED INSULIN COMPARED TO SUBCUTANEOUS HUMAN INSULIN$0
M01 · FY2000 · RR
EFFICACY AND SAFETY OF INHALED INSULIN COMPARED TO SUBCUTANEOUS HUMAN INSULIN$0
M01 · FY2000 · RR
IMPLANTABLE PUMP SYSTEM AND INSULIN IN PATIENT UNABLE TO ACHIEVE GLYCEMIC CONTROL$0
M01 · FY2000 · RR
IMPLANTABLE PUMP SYSTEM AND INSULIN IN PATIENT UNABLE TO ACHIEVE GLYCEMIC CONTROL$0
M01 · FY2000 · RR
COMPASSIONATE USE OF INHALED INSULIN IN ONE ADOLESCENT$0
M01 · FY2000 · RR
COMPASSIONATE USE OF INHALED INSULIN IN ONE ADOLESCENT$0
M01 · FY2000 · RR
NOCTURNAL HYPOGLYCEMIA EFFECT ON SLEEP PATTERNS OF DIABETIC CHILDREN$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL--TYPE I DIABETES (DPT 1)$0
M01 · FY2000 · RR
HORMONAL, SYMPTOMATIC AND NEUROPHYSIOLOGIC RESPONSE TO SUGAR INTAKE IN CHILDREN$0
M01 · FY2000 · RR
EFFECTS OF PUBERTY ON GLUCOSE KINETICS$0
M01 · FY2000 · RR
EFFECTS OF HOSPITALIZATION ON DIABETES MANAGEMENT$0
M01 · FY2000 · RR
MECHANISMS OF GLUCOSE INTOLERANCE IN CHILDREN WITH IDDM$0
M01 · FY2000 · RR